Skip to main content
Ingredients Barrier repair Bifida Ferment Lysate
29Bf
Sourced from microbe
Tier · Moderate evidence
Barrier repair · Anti-inflammatory

Bifida Ferment Lysate

INCI: Bifida Ferment Lysate · Also called: Probiotic Lysate

A probiotic-based ingredient that strengthens your skin's defenses against irritation and environmental stress.

For your skin

A probiotic-based ingredient that strengthens your skin's defenses against irritation and environmental stress.

Want the science? Keep reading ↓

Mechanism of action

Probiotic-derived lysate that supports DNA repair response and reinforces skin barrier function.

Why we tier this moderate

6 cited papers across 3 countries. The mechanism is well-described and there's at least one controlled trial in the literature, but we tier this Moderate rather than Strong to stay honest about how many specific papers we cite directly.

4
China
1
European Union
1
France

Cited research

🇨🇳

Zhu X et al., Protective effect of Bifidobacterium animalis CGMCC25262 on HaCaT keratinocytes, International Microbiology 2024;27(5):1417-1428 — B. animalis lysate upregulated HAS-2, AQP3, FLG and reduced RANTES under TNF-α/IFN-γ

🇨🇳

Wang Y et al., Short-term skin reactions and changes in stratum corneum following different ways of facial sheet mask usage, Journal of Tissue Viability 2024;33(4):831-839 — evaluated topical bifida ferment lysate masks on skin barrier measures

2024Positive (efficacy)PMID:38951050View source ↗
🇨🇳

Wang R et al., The pivotal role of Bifida Ferment Lysate on reinforcing the skin barrier function and maintaining homeostasis of skin defenses in vitro, Journal of Cosmetic Dermatology 2023;22(12):3427-3435 — BFL upregulated barrier and antioxidant genes; reduced inflammatory signaling

🇨🇳

Ma X et al., Bifidobacterium infantis strain YLGB-1496 possesses excellent antioxidant and skin barrier-enhancing efficacy in vitro, Experimental Dermatology 2022;31(7):1089-1094 — cell-free culture supernatant showed antioxidant + upregulated skin barrier genes

🇪🇺

Fabbrocini G et al., A Randomized, Double-Blind, Placebo-Controlled, Multicentric Study to Evaluate the Efficacy and Tolerability of a Class II Medical Device (containing bifida ferment lysate) in the Treatment of Mild and Moderate Acne, Dermatology and Therapy (Heidelberg) 2022;12(8):1835-1845 — topical bifida-ferment-lysate device reduced acne lesions vs placebo

2022Positive (efficacy)PMID:35861908View source ↗
🇫🇷

Guéniche A et al., Bifidobacterium longum lysate, a new ingredient for reactive skin, Experimental Dermatology 2010;19(8):e1-e8 — significant decrease in skin sensitivity and improved barrier function with 10% bacterial extract cream over 2 months

2010Positive (efficacy)PMID:19624730View source ↗

Sources: 10 clinical journals and regulatory databases across the US, EU, Korea, Japan, and China. Every entry points to a specific document. See methodology for the full list and what each outcome label means.